SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-425088
Filing Date
2016-01-08
Accepted
2016-01-08 17:16:33
Documents
5
Period of Report
2016-01-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d117580d8k.htm 8-K 15088
2 EX-99.1 d117580dex991.htm EX-99.1 6769
3 GRAPHIC g117580snap_mylanfooter1.jpg GRAPHIC 14867
4 GRAPHIC g117580snap_mylanfooter2.jpg GRAPHIC 3618
5 GRAPHIC g117580snap_mylanheader1.jpg GRAPHIC 12397
  Complete submission text file 0001193125-16-425088.txt   66231
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-199861 | Film No.: 161334350
SIC: 2834 Pharmaceutical Preparations